- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen-deprivation-associated bone disease
Authors
Keywords
-
Journal
CURRENT OPINION IN UROLOGY
Volume 24, Issue 6, Pages 601-607
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-08-21
DOI
10.1097/mou.0000000000000101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis
- (2014) D Brungs et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
- (2014) Tobias Engel Ayer Botrel et al. BMC Urology
- Androgens and prostate cancer; pathogenesis and deprivation therapy
- (2013) Mathis Grossmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer
- (2013) Michelle Nadler et al. BJU INTERNATIONAL
- Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications
- (2013) Yu-Hsuan Shao et al. BJU INTERNATIONAL
- A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
- (2013) Joshua M. Lang et al. Clinical Genitourinary Cancer
- Toxicities Following Treatment with Bisphosphonates and Receptor Activator of Nuclear Factor-κB Ligand Inhibitors in Patients with Advanced Prostate Cancer
- (2013) Benjamin A. Gartrell et al. EUROPEAN UROLOGY
- Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
- (2013) Vahakn B. Shahinian et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer
- (2013) David Chang et al. Journal of Medical Imaging and Radiation Oncology
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- (2013) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids
- (2013) B. García-Fontana et al. OSTEOPOROSIS INTERNATIONAL
- Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D
- (2013) S. M. H. Alibhai et al. OSTEOPOROSIS INTERNATIONAL
- Mortality following Hip Fracture in Men with Prostate Cancer
- (2013) Mieke Van Hemelrijck et al. PLoS One
- Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy
- (2013) Maria E. Suarez-Almazor et al. SUPPORTIVE CARE IN CANCER
- Osteoporosis Management Program Decreases Incidence of Hip Fracture in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy
- (2013) Ali-Asghar Zhumkhawala et al. UROLOGY
- Efficacy of Intermittent Androgen Deprivation Therapy vs Conventional Continuous Androgen Deprivation Therapy for Advanced Prostate Cancer: A Meta-analysis
- (2013) Huei-Ting Tsai et al. UROLOGY
- Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States
- (2013) Karynsa Cetin et al. UROLOGY
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
- (2012) Richard Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men
- (2012) Nathan K LeBrasseur et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy
- (2012) Susan L Greenspan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
- (2012) M. Datta et al. ONCOLOGIST
- Patients and partners lack knowledge of androgen deprivation therapy side effects
- (2012) Lauren M. Walker et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer
- (2010) Vahakn B. Shahinian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More